Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2006 1
2007 1
2008 1
2009 5
2010 5
2011 9
2012 18
2013 34
2014 33
2015 34
2016 23
2017 16
2018 33
2019 20
2020 10
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 24677555

204 results
Results by year
Filters applied: . Clear all
Page 1
Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, Floege J, Fliser D, Heine GH. Seiler S, et al. Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1049-58. doi: 10.2215/CJN.07870713. Epub 2014 Mar 27. Clin J Am Soc Nephrol. 2014. PMID: 24677555 Free PMC article.
Fibroblast growth factor-23 and cardiovascular events in CKD.
Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, Kusek JW, Feldman H, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Scialla JJ, et al. J Am Soc Nephrol. 2014 Feb;25(2):349-60. doi: 10.1681/ASN.2013050465. Epub 2013 Oct 24. J Am Soc Nephrol. 2014. PMID: 24158986 Free PMC article.
Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.
Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E, Weihrauch A, Fliser D, Heine GH. Seiler S, et al. Kidney Int. 2013 Jan;83(1):121-8. doi: 10.1038/ki.2012.288. Epub 2012 Aug 15. Kidney Int. 2013. PMID: 22895520 Free article.
Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH. Seiler-Mussler S, et al. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):569-576. doi: 10.2215/CJN.06620617. Epub 2018 Mar 5. Clin J Am Soc Nephrol. 2018. PMID: 29507005 Free PMC article.
Circulating α-klotho levels in CKD and relationship to progression.
Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH. Kim HR, et al. Am J Kidney Dis. 2013 Jun;61(6):899-909. doi: 10.1053/j.ajkd.2013.01.024. Epub 2013 Mar 27. Am J Kidney Dis. 2013. PMID: 23540260
Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.
Buiten MS, de Bie MK, Bouma-de Krijger A, van Dam B, Dekker FW, Jukema JW, Rabelink TJ, Rotmans JI. Buiten MS, et al. BMC Nephrol. 2014 Dec 11;15:197. doi: 10.1186/1471-2369-15-197. BMC Nephrol. 2014. PMID: 25495997 Free PMC article.
[Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA. Milovanova LY, et al. Ter Arkh. 2015;87(6):10-16. doi: 10.17116/terarkh201587610-16. Ter Arkh. 2015. PMID: 26281189 Russian.
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).
Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG. Ix JH, et al. J Am Coll Cardiol. 2012 Jul 17;60(3):200-7. doi: 10.1016/j.jacc.2012.03.040. Epub 2012 Jun 13. J Am Coll Cardiol. 2012. PMID: 22703926 Free PMC article.
Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH. Deo R, et al. Am J Kidney Dis. 2015 Jul;66(1):40-6. doi: 10.1053/j.ajkd.2014.10.025. Epub 2015 Jan 5. Am J Kidney Dis. 2015. PMID: 25572028 Free PMC article.
Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH. Emrich IE, et al. Am J Nephrol. 2019;49(3):203-211. doi: 10.1159/000497125. Epub 2019 Feb 26. Am J Nephrol. 2019. PMID: 30808827
204 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback